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ABSTRACT
Objective Endoscopic mucosal resection (EMR) is
established for the management of benign and early
malignant upper GI disease. The aim of this
observational study was to establish the effect of
endoscopist procedural volume on mortality.
Design Patients undergoing upper GI EMR between
1997 and 2012 were identiﬁed from the Hospital Episode
Statistics database. The primary outcome was 30-day
mortality and secondary outcomes were 90-day mortality,
requirement for emergency intervention and elective
cancer re-intervention. Risk-adjusted cumulative sum (RA-
CUSUM) analysis was used to assess patient mortality risk
during initial stage of endoscopist proﬁciency gain and
the effect of endoscopist and hospital volume. Mortality
was compared before and after the change point or
threshold in the RA-CUSUM curve.
Results 11 051 patients underwent upper GI EMR.
Endoscopist procedure volume was an independent
predictor of 30-day mortality. Fifty-eight per cent of EMR
procedures were performed by endoscopists with annual
volume of 2 cases or less, and had a higher 30-day and
90-day mortality rate for patients with cancer, 6.1% vs
0.4% (p<0.001) and 12% vs 2.1% (p<0.001),
respectively. The requirement for emergency intervention
after EMR for cancer was also greater with low volume
endoscopists (1.8% vs 0.1%, p=0.002). In patients with
cancer, the RA-CUSUM curve change points for 30-day
mortality and elective re-intervention were 4 cases and 43
cases, respectively.
Conclusions EMR performed by high volume
endoscopists is associated with reduced adverse
outcomes. In order to reach proﬁciency, appropriate
training and procedural volume accreditation training
programmes are needed nationally.
INTRODUCTION
The UK National audit showed that 25% of early
oesophagogastric cancers and 30% of early colorectal
cancers were managed by endoscopic resection in
2013.1 2 This increase in the uptake of endoscopic
therapy for cancer is coupled with a learning effect.
The proﬁciency gain curve for endoscopic submucosal
dissection in colorectal and gastric cancers ranges
from 25 to 40 cases, when considering complications,
operative time and R0 resection margin.3–5
Nevertheless, the vast majority of studies on the out-
comes of endoscopic mucosal resection (EMR) origi-
nates from single institutions, which does not reﬂect
the uptake of new techniques at a national level.
In recent years, the centralisation of surgical ser-
vices in the UK led to signiﬁcant improvement in
short-term outcomes of oesophageal and gastric
cancer surgical resection.6 The increase in hospital
and surgeon volume has been shown to be asso-
ciated with a reduction in postoperative mortality
from oesophagectomy and gastrectomy.7–9 The
reasons for this improvement in outcomes is that
high volume centres have the appropriate infra-
structure and surgical expertise to deliver a consist-
ent level of clinical outcomes from high-risk cancer
surgery.10 The effect of centre and clinician’s pro-
cedural volumes has not been similarly examined
for EMR previously.
Signiﬁcance of this study
What is already known on this subject?
▸ Advances in therapeutic endoscopy has led to
the endoscopic management of benign and
malignant upper GI disease.
▸ Increasing hospital and surgeon volume is
associated with a reduction in postoperative
mortality from oesophagectomy and
gastrectomy and has led to the centralisation of
surgical services.
What are the new ﬁndings?
▸ High volume endoscopists signiﬁcantly reduce
30-day mortality of endoscopic mucosal
resection, with endoscopist volume of greater
importance than hospital volume.
▸ The initial stage of endoscopist competency
gain is the most critical and is associated with
signiﬁcant mortality in the ﬁrst ﬁve cases.
▸ A longer endoscopist proﬁciency gain curve is
seen for analysis of oncological outcomes such
as the requirement for re-intervention in cancer
cases.
How might it impact on clinical practice in
the foreseeable future?
▸ Appropriate training and volume accreditation
are needed to minimise mortality and
requirement for re-intervention during the
initial stage of proﬁciency gain.
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The aim of this study was to establish the effect of the endos-
copist and hospital procedural volume and proﬁciency gain on
mortality and requirement for re-intervention from upper GI
EMR.
METHODS
Data were derived from the Hospital Episode Statistics (HES)
database.11 This is an administrative record-based system that
collects patient-level data from all National Health Service hos-
pitals in England. It captures all patients treated in public sector
hospitals and a minority of patients treated in privately funded
institutions. Patients are given a unique HES identiﬁer that
allows all of their hospital admissions to be tracked throughout
the data set.
All patients over the age of 17 years who underwent elective
endoscopic upper GI EMR between the 1st of January 1997
and the 31st of March 2012 were included in the study. EMRs
were identiﬁed using the Ofﬁce of Population Censuses and
Surveys Classiﬁcation of Surgical Operations and Procedures 4th
revision codes (G43.1, G43.8 and G43.9). Coding for EMR
was independently veriﬁed at a local institutional level. Patients
sent for emergency intervention within 14 days of the initial
EMR episode were identiﬁed using codes for repair or drainage
of oesophagus G07–09, repair of gastric perforation/injury
G34–36 and for endoscopic stent insertion G15.4, G15.6,
G15.7, G21.5 and G44.1. No patient within the data set
received emergency gastrectomy or oesophagectomy within
14 days of the initial EMR. Cancer diagnoses were identiﬁed
using the relevant International Classiﬁcation of Disease 10th
revision codes. The codes for oesophagogastric malignancy
included C15, C16, D00·1 and D00·2. Patients with oesophago-
gastric cancer with an inadequate initial EMR and likely positive
resection margin were identiﬁed through re-treatment after
30 days of the initial EMR, with oesophagectomy (G01, G02),
gastrectomy (G27, G28) or repeat EMR (G43.1, G43.8 and
G43.9).
The primary outcome was 30-day mortality; secondary out-
comes included 90-day mortality, requirement for emergency
intervention within 14 days, and in patients with oesophagogas-
tric cancer the requirement for elective re-intervention (repeat
EMR, oesophagectomy and gastrectomy) after 30 days.
Thirty-day and 90-day mortality were identiﬁed by linking HES
data with data from the Ofﬁce for National Statistics with 100%
population coverage. Outcomes were evaluated for EMR for the
treatment of patients with oesophagogastric cancer and for non-
cancer patients in separate analyses.
Risk-adjusted cumulative sum curve analysis
Endoscopist proﬁciency gain curve
To identify the existence and length of a proﬁciency gain curve
for EMR a combination of risk-adjusted cumulative sum
(RA-CUSUM) and change point analysis was performed.
RA-CUSUM curves were plotted for the cumulative difference
between the observed and the expected outcomes (Y axis)
against endoscopist case number (X axis); using the CUSUM
equation Si=Si−1+(Σi−ΣR); S0=0: Si is the cumulative sum, Σi
the sum of events at procedure number i and ΣR the sum of
expected events at procedure number i. Therefore at each case
number the curve goes upwards if the outcome is worse than
expected and downwards if the outcome is better than expected
(see online supplementary material 1). According to the unique
anonymised endoscopist codes within HES, the ﬁrst case in each
endoscopist case series was assigned case 1 and subsequent case
numbers assigned according to ascending date order. The
expected outcomes were derived from logistic regression models
for each binary outcome; these provided the predicted probabil-
ity of each outcome in each case. Potential confounding factors
included in the models were age, gender, Social Deprivation
Index and Charlson Comorbidity Index, all well recognised pre-
dictors of mortality provided in HES.
An inverse relationship was expected between experience and
adverse outcomes and the length of the proﬁciency gain curve
was deﬁned as the number of cases for a sustained improvement
in outcome. This was represented graphically on the CUSUM
curve as the maximal positive deﬂection, the point at which out-
comes changed from worse than expected to better than
expected. The clinical signiﬁcance of this change point was
determined by comparing outcomes before and after. These
binary outcomes were compared using the χ2 test and a thresh-
old of signiﬁcance was set at a p value of <0.05.
To identify the impact of the proﬁciency gain curve on the
volume-outcome relationship cumulative moving average (CMA)
30-day and 90-day mortality curves were compared for high
volume and low volume endoscopists (as deﬁned by the CUSUM
change point analysis above) for the ﬁrst eight cases. The CMA
curves were created using the equation CMAi=(x1+……..+xi)/i,
where xi is the mean mortality at procedure number i.
Endoscopist and hospital volume
RA-CUSUM analysis was also used to determine both the exist-
ence and the value of any endoscopist or hospital volume
threshold. The volume threshold was deﬁned as the minimum
annual case load for an alteration in volume-outcome relation-
ships. Similar to the proﬁciency gain curve analysis above the
curve plots the cumulative difference between the observed and
the expected mortality, against the endoscopist or hospital
volume. On the basis of this deﬁnition, the curve goes upwards
every time the observed mortality exceeds the expected mortal-
ity and vice versa. As an inverse relationship between volume
and mortality, emergency intervention and elective
re-intervention was expected, the hypothesis was that the
volume threshold would coincide where the curve peaked.
Hierarchical multivariate regression analysis with Bonferroni
correction was performed to identify the most important
patient factors and endoscopist or hospital volume (as deﬁned
by CUSUM change point analysis above) associated with 30-day
mortality. Patient variables included in this model were age,
gender and medical comorbidities (as reﬂected by the Charlson
Comorbidity Index). To evaluate the inﬂuence of endoscopist
subspecialty, data from a previous oesophagectomy gastrectomy
data set were linked to identify cancer surgeons performing
endoscopy, and included in the regression models for the cancer
cohort only. Hierarchical logistic regression included three
models; (1) patient comorbidities, cancer surgeon specialty and
only endoscopist volume, (2) patient comorbidities, cancer
surgeon specialty and only hospital volume, and (3) patient
comorbidities, cancer surgeon specialty hospital and endoscopist
volume.
CUSUM curves were computed using Excel (Excel for Mac
2011, V.14.1.4, Microsoft Corporation). For the remaining stat-
istical analysis SPSS V.22.0 was used (Statistical Package for the
Social Sciences software, Chicago, Illinois, USA). Change point
modelling was performed in R (V.3.2.3).
RESULTS
The demographics of the patients undergoing EMR are
described in table 1. The effects of endoscopist proﬁciency gain
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and endoscopist/hospital volume upon clinical outcomes are
described in tables 2 and 3, respectively.
Within the study period 11 051 patients underwent upper GI
EMR, with 1078 EMR procedures performed for oesophageal
or gastric cancer and 9973 for non-cancer cases. Other
common non-cancer diagnostic indications for EMR included
gastric polyps (2942 patients, 29.5%), benign gastric neoplasms
(2465 patients, 24.7%), oesophageal or gastric ulcers (1702
patients, 17.1%) and Barrett’s oesophagus (914 patients, 9.2%).
There was a steady increase in EMR performed over the study
period from 1354 (12.3%) in early years (1997–2000) to 4566
(41.3%) in later years (2009–2012). In particular there was an
increase in the number of EMRs performed for oesophagogas-
tric cancer over time, from 85 (7.9%) in 1997–2000 to 538
(49.9%) in 2009–2012. The percentage 30-day and 90-day
mortalities over the study period were 1.2% and 2.7%, respect-
ively, for all patients. There was a reduction in 30-day mortality
(1.8% to 0.8%, p<0.001) and 90-day mortality (3.6% to 1.8%,
p<0.001) over the study period.
Endoscopist RA-CUSUM curve analysis
Analysis of the RA-CUSUM curve for the non-cancer cohort of
9973 patients undergoing EMR showed a signiﬁcant change
point at two cases where a signiﬁcant reduction in 30-day mor-
tality was observed from 1.8% to 0.5% (p<0.001) (ﬁgure 1,
table 2). There was a similar change point for 90-day mortality
at two cases where the mortality rate decreased from 3.6% to
1.3% (p<0.001). There was no identiﬁable change point in the
RA-CUSUM curve for the need for emergency intervention in
the non-cancer cohort.
Analysis of patients receiving EMR for oesophagogastric
cancer showed a change point at four cases, where a signiﬁcant
reduction in 30-day mortality was observed from 4.5% to 0.3%
(p<0.001). The change point for 90-day mortality was two
cases with a reduction in 90-day mortality from 10.8% to 2.6%
(p<0.001). The requirement for emergency intervention within
14 days of initial EMR had a change point at one case with sig-
niﬁcant reductions of 1.5% to 0.1% (p=0.009). The require-
ment for elective re-intervention at least 30 days after initial
EMR showed a longer proﬁciency gain with a change point at
43 cases, and a signiﬁcant reduction from 24.6% to 10.8%
(p=0.005); surgical resection fell from 15.3% to 5.3%
(p=0.017) and repeat EMR fell from 9.3% to 5.3%
(p=0.238).
The CMA curves for the low volume and high volume endos-
copists reveal a gradual decrease in both 30-day mortality and
90-day mortality consistent with the CUSUM curves. The
curves for low volume endoscopists over the initial eight cases
are equivalent to high volume endoscopists, suggesting that over
time they would reach a similar level of proﬁciency (ﬁgure 2).
Endoscopist and hospital volume-outcome RA-CUSUM
analysis
The median annual endoscopist EMR volume was 1.9 (range 1–
28.6) with 58% of EMR procedures being performed by endos-
copists that performed two or less EMR procedures annually.
RA-CUSUM analysis of 30-day mortality and 90-day mortal-
ity for endoscopist annual volume of only cancer cases showed
signiﬁcant change points at two procedures per year with reduc-
tion in observed mortality from 6.1% to 0.4% (p<0.001) and
12% to 2.1%, (p<0.001), respectively (table 3). There was also
a signiﬁcant reduction in the requirement for emergency inter-
vention in endoscopists that performed more one case per year
(1.8% to 0.1%, p<0.002). The endoscopist volume threshold
for elective re-intervention in cancer cases was also greater at
eight cases with a signiﬁcant reduction from 24.2% to 17.5%
Table 1 Preoperative demographics for patients undergoing
endoscopic mucosal resection
Preoperative demographic
Non-cancer
patients (%)
(n=9973)
Patients with
oesophagogastric
cancer (%)
(n=1078)
Age ≥70 years 4669 (46.8) 694 (64.4)
Male ratio 5109 (51.2) 709 (65.8)
Congestive cardiac failure 93 (0.9) 13 (1.2)
Ischaemic heart disease 389 (3.9) 69 (6.4)
Liver disease 74 (0.7) 5 (0.5)
Peripheral vascular disease 40 (0.4) 12 (1.1)
Pulmonary disease 542 (5.4) 94 (8.7)
Renal disease 118 (1.2) 15 (1.4)
Charlson Comorbidity Index
≥3
424 (4.3) 687 (63.7)
Table 2 Changes in clinical outcomes from EMR before and after change point in RA-CUSUM curve analysis for endoscopist proficiency gain
(A) non-cancer patients and (B) patients with oesophagogastric cancer
Outcome Change point Overall rate Before change point After change point p Value
(A) Non-cancer patients
Emergency intervention No PGC – – – –
30-day mortality 2 cases 1.0% (0.8% to 1.2%) 1.8% (1.4% to 2.3%) 0.5% (0.4% to 0.7%) <0.001
90-day mortality 2 cases 2.2% (2.0% to 2.5%) 3.6% (3.1% to 4.3%) 1.3% (1.1% to 1.7%) <0.001
(B) Patients with oesophagogastric cancer
Emergency intervention 1 case 0.6% (0.3% to 1.3%) 1.5% (0.7% to 3.2%) 0.1% (0.0% to 0.8%) 0.009
30-day mortality 4 cases 3.1% (2.2% to 4.3%) 4.5% (3.2% to 6.3%) 0.3% (0.1% to 1.5%) <0.001
90-day mortality 2 cases 6.8% (5.4% to 8.4%) 10.8% (8.4% to 13.6%) 2.6% (1.5% to 4.3%) <0.001
Re-intervention 43 cases 23.6% (21.1% to 26.2%) 24.6% (22.0% to 27.3%) 10.8% (5.4% to 19.4%) 0.005
Oesophagectomy/gastrectomy 14.6% (12.9% to 16.8%) 15.3% (13.2% to 17.6%) 5.3% (2.1% to 12.8%) 0.017
Repeat EMR 9.0% (7.4% to 10.9%) 9.3% (7.6% to 11.2%) 5.3% (2.1% to 12.8%) 0.238
Emergency intervention was defined as an acute emergency operation or endoscopic stent insertion performed within 14 days of the primary EMR procedure.
Re-intervention was defined as repeat EMR, oesophagectomy or gastrectomy for the treatment of cancer at least 30 days following the initial EMR procedure.
EMR, endoscopic mucosal resection; PGC, proficiency gain curve; RA-CUSUM, risk-adjusted cumulative sum.
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Table 3 Changes in clinical outcomes from EMR before and after threshold in RA-CUSUM curve analysis for patients with cancer by (A) annual
endoscopist volume and (B) annual hospital volume
Variable
Volume threshold
per year Overall rate Below Above p Value
Endoscopist annual volume
Emergency intervention 1 case 0.6% (0.3% to 1.3%) 1.8% (0.8% to 3.9%) 0.1% (0.0% to 0.7%) 0.002
30-day mortality 2 cases 3.1% (2.2% to 4.3%) 6.1% (4.3% to 8.5%) 0.4% (0.1% to 1.3%) <0.001
90-day mortality 2 cases 6.8% (5.4% to 8.4%) 12.0% (9.4% to 15.1%) 2.1% (1.2% to 3.7%) <0.001
Re-intervention 8 cases 23.6% (21.1% to 26.8%) 24.2% (21.1% to 27.3%) 17.5% (13.5% to 22.2%) 0.033
Hospital annual volume
Emergency intervention 5 cases 0.6% (0.3% to 1.3%) 1.6% (0.7% to 3.6%) 0.3% (0.1% to 1.0%) 0.016
30-day mortality 8 cases 3.1% (2.2% to 4.3%) 5.3% (3.6% to 7.7%) 1.2% (0.6% to 2.4%) <0.001
90-day mortality 8 cases 6.8% (5.4% to 8.4%) 10.8% (8.3% to 13.8%) 3.4% (2.2% to 5.2%) <0.001
Re-intervention No curve 23.6% (21.1% to 26.8%) NA NA NA
Emergency intervention was defined as an acute emergency operation or endoscopic stent insertion performed within 14 days of the primary EMR procedure.
Re-intervention was defined as repeat EMR, oesophagectomy or gastrectomy for the treatment of cancer at least 30 days following the initial EMR procedure.
EMR, endoscopic mucosal resection; RA-CUSUM, risk-adjusted cumulative sum.
Figure 1 National risk-adjusted cumulative sum (RA-CUSUM) curves of non-cancer endoscopic mucosal resection (EMR) cases and of EMR for
oesophagogastric cancer showing signiﬁcant change points in clinical outcomes for EMR during endoscopist proﬁciency gain.
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(p=0.033). Analysis of non-cancer cases showed a signiﬁcant
endoscopist volume threshold at one case for 30-day mortality
and 90-day mortality, with reduction in observed mortality
from 1.3% to 0.6% (p<0.001) and 2.8% to 1.6% (p<0.001),
respectively.
To account for the impact of the proﬁciency gain curve
30-day mortality and 90-day mortality analysis was repeated for
endoscopist annual volume after the ﬁrst four cases. For the
cancer cases there was a reduction from 2.5% to 0.2%
(p=0.007) and from 6.8% to 1.1% (p<0.001) in 30-day mor-
tality and 90-day mortality, respectively. In the non-cancer
cohort there was no obvious annual volume threshold after the
ﬁrst four cases.
The median annual hospital EMR volume was 6.5 (range 1–
28.9) with 56.5% of EMR procedures being performed in hos-
pitals that performed eight or less EMR procedures annually.
RA-CUSUM analysis of 30-day mortality and 90-day mortality
for hospital annual volume of only cancer cases showed
signiﬁcant change points at eight cases per year, with reduction
in observed mortality from 5.3% to 1.2% (p<0.001) and
10.8% to 3.4% (p<0.001), respectively. There was also a statis-
tically signiﬁcant requirement for emergency intervention by
hospitals that performed more than ﬁve cases per year (1.6% to
0.3%, p=0.016). Analysis of non-cancer cases showed a hospital
volume threshold at ﬁve cases for 30-day mortality and 90-day
mortality, with reductions in observed mortality from 1.3% to
0.7%, (p=0.005) and 2.5% to 2.0% (p=0.065), respectively.
There were no statistically signiﬁcant differences in Charlson
Comorbidity Index (CCI) and in patient age between the high
volume and low volume hospitals.
Multivariate analysis for 30-day mortality
The Spearman’s rank correlation coefﬁcient between annual
hospital and endoscopist volume was 0.447 (p<0.001)
(table 4). Therefore, to identify the relative importance of
annual hospital volume versus endoscopist volume, hierarchical
multivariate analysis for patients with cancer (see online
supplementary material 2) conﬁrmed that endoscopist annual
volume was the only signiﬁcant factor in reducing 30-day mor-
tality from EMR (OR=0.34; 95% CI 0.17 to 0.68, p=0.002)
(table 4), assuming greater signiﬁcance than hospital volume
and cancer surgeon endoscopist. A similar result was observed
for the non-cancer cohort with endoscopist annual volume
assuming greater importance than hospital volume in reducing
30-day mortality (OR=0.55; 95% CI 0.32 to 0.96, p=0.034).
Other factors signiﬁcantly increasing 30-day mortality included
age ≥70 years and Charlson Comorbidity Index score ≥3.
DISCUSSION
Over the study period a threefold increase was observed in the
number of patients undergoing oesophagogastric EMR with a
marked increase in cancer resection. The endoscopist workload
was an independent predictor for mortality. Fifty-eight per cent
of EMR procedures were performed by endoscopists with
annual volume of two cases or less, with a 12-fold and 6-fold
increase in 30-day mortality rate and 90-day mortality rate,
respectively, for patients with cancer. The requirement for emer-
gency intervention after EMR was greater with low volume
endoscopists. However no patient within the data set received
emergency gastrectomy or oesophagectomy within 14 days of
the initial EMR, suggesting complications were detected late or
were extremely severe. Multivariate analysis demonstrated that
risk factors for 30-day mortality and 90-day mortality include
endoscopist procedural volume, and patient age and comorbid-
ities including cardiac failure, and renal, peripheral vascular and
liver disease. In patients with cancer analysis of elective
Figure 2 Thirty-day mortality and 90-day mortality cumulative
moving average (CMA) curves for low volume (LV) and high volume
(HV) endoscopists, demonstrating similar clinical outcomes during the
early component of learning endoscopic mucosal resection.
Table 4 Hierarchical multivariate regression analysis for 30-day mortality following upper GI EMR
Variable
Cancer cohort Non-cancer cohort
OR 95% CI p Value OR 95% CI p Value
Age ≥70 years 3.14 1.29 to 7.60 0.011 2.01 1.33 to 3.04 0.001
Female gender 1.08 0.55 to 2.10 0.821 0.54 0.36 to 0.82 0.003
Charlson Comorbidity Index ≥3 2.22 1.06 to 4.69 0.036 5.18 3.13 to 8.59 <0.001
Endoscopist volume* 0.34 0.17 to 0.68 0.002 0.55 0.32 to 0.96 0.034
Hospital volume† 0.69 0.34 to 1.37 0.283 0.74 0.45 to 1.21 0.230
Cancer surgeon endoscopist 0.72 0.27 to 1.88 0.502 – – –
*Endoscopist volume threshold of two cases per year used to dichotomise study cohort.
†Hospital volume of eight cases per year used to dichotomise study cohort.
EMR, endoscopic mucosal resection.
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re-intervention with repeat EMR, oesophagectomy or gastrec-
tomy showed a longer proﬁciency gain curve and a similarly
greater volume threshold to cause a signiﬁcant reduction in
incidence.
Over 50% of EMR procedures were performed by endosco-
pists that perform less two cases annually, which raises concern
over the number of endoscopists who are performing a low
number of EMR procedures. About 337 endoscopists (83%) per-
formed <17 cases over the entire study period with the initial
period of the proﬁciency gain curve being the most dangerous
component (as the RA-CUSUM curve demonstrated an early
change point in mortality). When procedures were undertaken
for oesophagogastric cancer, the change point was at four cases
with a 15-fold decrease in 30-day mortality following the change
point. There were also signiﬁcant changes in 90-day mortality
for both the cancer and the non-cancer groups, and in patients
with cancer, emergency intervention reduced following the
change point during the initial stage of competency gain. The
CMA curves suggest that the low volume endoscopists were
learning at a similar rate as their high volume counterparts. The
difference in outcomes between low volume and high volume
endoscopists can be explained by the fact that low volume endos-
copists have not progressed as far along the proﬁciency gain
curve to compensate for the earlier poor outcomes. In cancer
cases, the proﬁciency gain curve for elective re-intervention with
repeat EMR, oesophagectomy or gastrectomy for presumed
positive resection margin and failure of initial EMR was substan-
tially longer at 43 cases. This highlights the technical challenges
in assuring oncological quality and adequate resection associated
with EMR, and therefore the substantially longer proﬁciency
gain curve with a high re-intervention rate of 23.6%.
The reduction in 30-day mortality seen with high hospital
volume in RA-CUSUM analysis was due to the correlation with
high endoscopist volume. Hierarchical logistic regression
showed a greater relative importance of high endoscopist
volume over high hospital volume in reducing 30-day mortality.
In oesophagogastric cancer surgery the established
volume-outcome relationship has led to the centralisation of ser-
vices and a demonstrated improvement in patient outcomes
with reduction in surgically related mortality.10 The endoscopist
volume-outcome relationship in this study puts forward a com-
pelling argument that endoscopic management of these cancers
should also be restricted to high volume endoscopists in centres
with specialist multidisciplinary teams where more appropriate
patient selection and better clinical outcomes are achievable.
The scale of change in early mortality in the initial stage of
competency gain, particularly for cancer, raises concern regard-
ing the method of introducing new endoscopic techniques into
clinical practice. Gaining experience at the expense of patient
safety is unethical and efforts must be made to avoid mortality
as an outcome of proﬁciency gain. Other end points such as
execution time are acceptable parameters. Structured training
programmes with competency-based assessment and accredit-
ation process are required at a national level. The trainee’s per-
formance of EMR is currently assessed using the Direct
Observation of Procedural Skills therapeutic upper GI endos-
copy tool and requires formal sign-off by a trainer.12 Trusts are
required to submit the outcomes of EMR for cancer and high-
grade dysplasia to the National Oesophago-Gastric Cancer
Audit. The National Training Program for Laparoscopic
Colorectal Surgery in England is a good model where clinical
outcomes were not compromised while trainees gained compe-
tency.13 During the training programme and in subsequent clin-
ical practice, mortality and complication rates of cases
performed by trainees were equivalent to those achieved by
experts.14 The most common method of monitoring the intro-
duction of a new technique is through audit that records mor-
bidity and mortality, however audits only detect adverse events
after patient harm has occurred. A more sensitive approach is
the use of error analysis and near-miss event,15 16 to analyse
technical performance in order to identify those who require
more training to reach proﬁciency, a standard practice in high
reliability organisations.
There are important limitations to this study including its
design as a retrospective observational study. The administrative
data are limited by the lack of cancer-speciﬁc information such
as stage with its prognostic implications. However given the util-
isation of EMR primarily for early stage cancers, progression of
cancer is unlikely to have inﬂuenced the mortality data pre-
sented in this study. Further it is likely that coding errors may
have led to some patients in the non-cancer group being mis-
coded and actually being treated for oesophagogastric cancer.
The limitations of coding are inherent to any national adminis-
trative database. Identiﬁcation of individual practitioners within
the HES database was made using a unique anonymised
provider-speciﬁc code for the endoscopist associated with that
hospital episode and discharge. In some circumstances a col-
league or a trainee endoscopist may have performed the proced-
ure, and therefore those procedures would have been captured
within the senior coded practitioner’s RA-CUSUM curve ana-
lysis, a limitation shared by all national databases. Further this
study has identiﬁed changes in mortality associated with endos-
copist and hospital procedural volume, however the cause of
mortality cannot be accurately assessed using the data provided
within this administrative database. Data were extracted over a
prolonged time frame to include the whole case series of the
majority of endoscopists. It should be recognised there may
have been signiﬁcant changes in EMR technique and practice
which may have inﬂuenced the results, although the majority of
endoscopists started their practice later in the study. Further the
primary aim of this study was to retrospectively identify how
many cases the endoscopists took to gain proﬁciency in order to
guide training, future practice and possible centralisation of ser-
vices. Chances in performance over time are not as relevant to
this study as we are not prospectively monitoring the current
treatment failure rate. Also, learning from other endoscopic pro-
cedures not captured within the study may have affected the
length of the proﬁciency gain curves observed. However these
are likely to be equally distributed between endoscopists
included in the study. Despite the retrospective design of the
study and possible confounding factors over time, the conclu-
sions of the study are accurate given the majority of endosco-
pists started their practice later in the study, and a repeated
analysis that factored in changes over time demonstrating similar
results (see online supplementary material 3).17
The introduction of oesophagogastric EMR has been asso-
ciated with an increase in the number of patients receiving
endoscopic management of cancer. The volume of procedures
undertaken at an institutional level and most importantly at an
endoscopist level is directly related to patient mortality.
Appropriate training and volume accreditation are needed to
minimise mortality and requirement for re-intervention during
the initial stage of proﬁciency gain.
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